Eating behavior modification

"Eating behavior modification" is an umbrella term denoting strategies and interventions—biological, psychological, behavioral, or environmental—used to alter food intake patterns in humans. These modifications are achieved through influencing central (hypothalamic, limbic, cerebellar, and cortical) and peripheral (gut, adipose) pathways, and are relevant in the prevention and treatment of obesity, metabolic syndrome, and eating disorders. The underlying biological mechanisms include modulation of hunger/satiety peptides (ghrelin, leptin, CCK), taste receptors (TAS1R, TAS2R), gut-brain signaling, self-regulatory brain networks, and psychosocial environment[1][2][3][5][6][7]. However, the phrase does not identify a specific molecule, gene, receptor, or protein, and should not be treated as a canonical drug target or molecular entity. Key points: - "Eating behavior modification" describes a process or therapeutic goal, not a molecular target. - It involves multidisciplinary pathways, including neurotransmitters (serotonin, dopamine), hormonal signals (ghrelin, leptin, insulin), taste and reward pathways, and psychosocial dynamics[1][2][3][6][7]. - Drugs and interventions can affect eating behavior (e.g., GLP-1 receptor agonists, appetite suppressants, behavioral therapies), but these act on molecular targets (GLP-1 receptor, serotonin transporter, etc.), not on "eating behavior modification" itself[1]. - This term should not be included in structurally organized databases of molecular targets; instead, one should identify the specific molecular or neural targets relevant to the intervention under consideration.

Other names

appetite regulationeating pattern interventiondietary behavior changeeating habit modification